A new phenotypic classification system for dyslipidemias based on the standard lipid panel

Area of Science:

• Cardiovascular Medicine
• Clinical Chemistry
• Genetics

Background:

• Dyslipoproteinemias classification traditionally requires advanced laboratory testing.
• Accurate lipoprotein phenotyping is crucial for assessing atherosclerotic cardiovascular disease (ASCVD) risk.
• Current methods for classifying lipoprotein patterns can be complex and resource-intensive.

Purpose of the Study:

• To develop a novel algorithm for classifying lipoprotein disorders.
• The algorithm aims to utilize only standard lipid panel results.
• This seeks to simplify and improve accessibility of lipoprotein phenotyping.

Main Methods:

• Derived lipid thresholds for Non-High-Density Lipoprotein-Cholesterol (NonHDL-C) and Triglycerides (TG).
• Ensured concordance with existing US Multi-Society guidelines where possible.
• Validated the algorithm using NMR lipid analysis and agarose gel electrophoresis.

Main Results:

• The new system categorizes patients into classical Fredrickson-like phenotypes (excluding Type III).
• Identified a novel hypolipidemic phenotype (Type VI) linked to apoB-metabolism mutations.
• Demonstrated that lipoprotein phenotypes significantly associate with ASCVD risk and can serve as prognostic indicators.

Conclusions:

• A clinically practical lipoprotein phenotyping system based solely on the standard lipid panel has been developed.
• This system can be readily implemented to enhance guideline compliance.
• It offers a pathway to improved patient care for those at risk of ASCVD.